320 related articles for article (PubMed ID: 26543874)
21. Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.
Kato S; Berzofsky JA; Terabe M
Front Immunol; 2018; 9():314. PubMed ID: 29520281
[TBL] [Abstract][Full Text] [Related]
22. Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis.
Yang JQ; Zhou Y; Singh RR
J Immunol Res; 2016; 2016():2395645. PubMed ID: 27563682
[TBL] [Abstract][Full Text] [Related]
23. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
24. Targeting Natural Killer T Cells in Solid Malignancies.
Ingram Z; Madan S; Merchant J; Carter Z; Gordon Z; Carey G; Webb TJ
Cells; 2021 May; 10(6):. PubMed ID: 34072042
[TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
[TBL] [Abstract][Full Text] [Related]
26. Natural killer T cells in pulmonary disorders.
Rijavec M; Volarevic S; Osolnik K; Kosnik M; Korosec P
Respir Med; 2011 Oct; 105 Suppl 1():S20-5. PubMed ID: 22015081
[TBL] [Abstract][Full Text] [Related]
27. Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.
Lam PY; Nissen MD; Mattarollo SR
Front Immunol; 2017; 8():1355. PubMed ID: 29109728
[TBL] [Abstract][Full Text] [Related]
28. Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer.
Fujii SI; Shimizu K
Trends Immunol; 2019 Nov; 40(11):984-997. PubMed ID: 31676264
[TBL] [Abstract][Full Text] [Related]
29. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?
Kulkarni RR; Haeryfar SM; Sharif S
J Leukoc Biol; 2010 Oct; 88(4):635-43. PubMed ID: 20519638
[TBL] [Abstract][Full Text] [Related]
30. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
Fujii S
Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
[No Abstract] [Full Text] [Related]
31. Activation and Function of iNKT and MAIT Cells.
Chandra S; Kronenberg M
Adv Immunol; 2015; 127():145-201. PubMed ID: 26073984
[TBL] [Abstract][Full Text] [Related]
32. mTOR and its tight regulation for iNKT cell development and effector function.
Yang W; Gorentla B; Zhong XP; Shin J
Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
[TBL] [Abstract][Full Text] [Related]
33. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.
Van Kaer L; Parekh VV; Wu L
Immunotherapy; 2011 Jan; 3(1):59-75. PubMed ID: 21174558
[TBL] [Abstract][Full Text] [Related]
34. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
Swain MG
Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
[TBL] [Abstract][Full Text] [Related]
35. Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States.
Khurana P; Burudpakdee C; Grupp SA; Beier UH; Barrett DM; Bassiri H
Front Immunol; 2021; 12():700374. PubMed ID: 34434191
[TBL] [Abstract][Full Text] [Related]
36. From the Deep Sea to Everywhere: Environmental Antigens for iNKT Cells.
Wingender G
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):291-8. PubMed ID: 26703211
[TBL] [Abstract][Full Text] [Related]
37. Innate-like behavior of human invariant natural killer T cells during herpes simplex virus infection.
Novakova L; Nevoralova Z; Novak J
Cell Immunol; 2012; 278(1-2):16-20. PubMed ID: 23121971
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
39. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
Noma H; Eshima K; Satoh M; Iwabuchi K
Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
[TBL] [Abstract][Full Text] [Related]
40. NKT-cell-based immunotherapies in clinical trials.
Exley MA; Nakayama T
Clin Immunol; 2011 Aug; 140(2):117-8. PubMed ID: 21592864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
